# Comparative Accuracy of Semiconductor Single-Photon Emission Computed Tomography (SPECT) Versus Cardiac Magnetic Resonance (CMR) for Myocardial Viability Assessment

**Authors:** Arata Sano, Satoaki Matoba, Koshi Miyake, Sachiyo Ono, Takeshi Tada, Takeshi Maruo, Kazushige Kadota

PMC · DOI: 10.7759/cureus.83679 · Cureus · 2025-05-07

## TL;DR

This study compares the accuracy of semiconductor SPECT and cardiac MRI in assessing heart muscle viability, finding strong agreement between the two methods.

## Contribution

The study provides the first direct comparison of D-SPECT and CMR for myocardial viability assessment in the same patient cohort.

## Key findings

- D-SPECT showed high diagnostic accuracy (area under the curve: 0.97) when compared to CMR late gadolinium enhancement.
- Patients receiving OMT + PCI/CABG had significant improvements in ejection fraction compared to OMT alone.
- Five-year survival rates did not significantly differ between OMT and OMT + PCI/CABG groups.

## Abstract

Background

Evaluating myocardial viability is critical for developing optimal strategies for ischemic cardiomyopathy. While semiconductor single-photon emission computed tomography (D-SPECT) demonstrated higher image quality than conventional Anger cameras for assessing myocardial viability, its accuracy compared to cardiac magnetic resonance (CMR) in the same patient cohort is still unknown.

Methods

We conducted a retrospective study on patients with known or suspected coronary artery disease who underwent D-SPECT and CMR within 100 days. Rest deficit score on D-SPECT and depth of contrast enhancement on late gadolinium enhancement (LGE) in CMR were classified and compared using a 16-segment analysis. Follow-up echocardiography was performed about a year after the initial examinations, detecting whether the optimal medical therapy (OMT) was followed by invasive therapy (coronary artery bypass grafting [CABG] or percutaneous coronary intervention [PCI]). The five-year survival rates were also compared.

Results

The study comprised 336 segments from 21 consecutive patients collected between January 2015 and December 2017. Using LGE as a viability criterion, a D-SPECT score of three had the highest diagnostic accuracy (area under the curve: 0.97). Follow-up echocardiography showed significant improvements in left ventricular ejection fraction in patients receiving OMT + PCI/CABG compared to OMT alone (OMT vs. OMT + PCI/CABG; 1.5% ± 3.4% vs. 7.1% ± 5.0%, p = 0.008); five-year survival rate did not significantly differ between the groups.

Conclusions

Deficits observed at rest on D-SPECT and LGE extent on CMR showed a strong correlation in evaluating myocardial viability, implying that D-SPECT is a viable alternative to CMR for this purpose.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010)

## Full-text entities

- **Diseases:** coronary artery disease (MESH:D003324), ischemic cardiomyopathy (MESH:D009202)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12058546/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12058546/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12058546/full.md

---
Source: https://tomesphere.com/paper/PMC12058546